Department of Endocrinology and Metabolic diseases, Cardiovascular and Metabolic Unit CHU-Larrey, Toulouse, France.
Endocrine. 2021 May;72(2):326-331. doi: 10.1007/s12020-021-02689-y. Epub 2021 Mar 27.
The world is dealing with the Covid-19 pandemic due to the coronavirus SARS-CoV-2. Amongst the extra-pulmonary manifestations presented by Covid-19 patients, thyroiditis form part of the spectrum of visceral involvement linked to SARS-CoV-2. In this review, we will describe the various documented clinical forms of thyroiditis (inflammatory thyroiditis, subacute or de Quervain's thyroiditis, chronic lymphocytic thyroiditis or Hashimoto's disease, painless (silent) postpartum thyroiditis) to facilitate their diagnosis in more or less symptomatic Covid-19 patients and to provide guidance for patient treatment.
由于冠状病毒 SARS-CoV-2，世界正在应对 COVID-19 大流行。在 COVID-19 患者出现的肺外表现中，甲状腺炎是与 SARS-CoV-2 相关的内脏受累谱的一部分。在这篇综述中，我们将描述各种已记录的甲状腺炎临床形式（炎症性甲状腺炎、亚急性或 De Quervain 甲状腺炎、慢性淋巴细胞性甲状腺炎或桥本氏病、无痛（沉默）产后甲状腺炎），以促进在或多或少有症状的 COVID-19 患者中诊断这些疾病，并为患者治疗提供指导。
